These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32732624)

  • 21. Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate.
    Maxeiner A; Kittner B; Blobel C; Wiemer L; Hofbauer SL; Fischer T; Asbach P; Haas M; Penzkofer T; Fuller F; Miller K; Cash H
    BJU Int; 2018 Aug; 122(2):211-218. PubMed ID: 29569320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy.
    Klingebiel M; Arsov C; Ullrich T; Quentin M; Al-Monajjed R; Mally D; Sawicki LM; Hiester A; Esposito I; Albers P; Antoch G; Schimmöller L
    Eur J Radiol; 2021 Apr; 137():109587. PubMed ID: 33592552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined MRI-TRUS fusion targeted and systematic biopsy versus systematic biopsy alone for the detection of prostate cancer: protocol for a prospective single-centre trial.
    Liu W; Kadier A; Shen D; He Y; Dong S; Zhu K; Xu G; Zhao B; Mao S; Guo C; Yao X; Wei Q; Han D; Yang B
    BMJ Open; 2024 Mar; 14(3):e080593. PubMed ID: 38431292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study.
    Duwe G; Schmitteckert M; Haack M; Sparwasser P; Dotzauer R; Thomas A; Tsaur I; Brandt MP; Kurosch M; Mager R; Haferkamp A; Boehm K; Höfner T
    World J Urol; 2024 May; 42(1):297. PubMed ID: 38709326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Detection Rates in Targeted Transperineal MRI-TRUS Elastic Fusion-guided Prostate Biopsies Performed Under Local Anesthesia.
    Jacewicz M; Rud E; Galtung KF; Noor D; Baco E
    Anticancer Res; 2021 Sep; 41(9):4395-4400. PubMed ID: 34475059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?
    Liu H; Ruan M; Wang H; Wang H; Li X; Song G
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):589-595. PubMed ID: 32719353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies.
    Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J
    Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
    Rouvière O; Puech P; Renard-Penna R; Claudon M; Roy C; Mège-Lechevallier F; Decaussin-Petrucci M; Dubreuil-Chambardel M; Magaud L; Remontet L; Ruffion A; Colombel M; Crouzet S; Schott AM; Lemaitre L; Rabilloud M; Grenier N;
    Lancet Oncol; 2019 Jan; 20(1):100-109. PubMed ID: 30470502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis.
    Dariane C; Ploussard G; Barret E; Beauval JB; Brureau L; Créhange G; Fromont G; Gauthé M; Mathieu R; Renard-Penna R; Roubaud G; Ruffion A; Sargos P; Rouprêt M; Fiard G;
    World J Urol; 2023 Mar; 41(3):641-651. PubMed ID: 35835886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted and Systematic Prostate Biopsy in Biopsy-naive Men With Positive Multiparameter Magnetic Resonance Imaging Findings: A Meta-analysis.
    Jiang G; Zhang G; Chen S; Chen M
    Clin Genitourin Cancer; 2020 Apr; 18(2):105-110.e5. PubMed ID: 31902712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transperineal Magnetic Resonance Imaging-Targeted Biopsy May Perform Better Than Transrectal Route in the Detection of Clinically Significant Prostate Cancer: Systematic Review and Meta-analysis.
    Tu X; Liu Z; Chang T; Qiu S; Xu H; Bao Y; Yang L; Wei Q
    Clin Genitourin Cancer; 2019 Oct; 17(5):e860-e870. PubMed ID: 31281065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions.
    Wang F; Chen T; Wang M; Chen H; Wang C; Liu P; Liu S; Luo J; Ma Q; Xu L
    BMC Urol; 2021 Dec; 21(1):183. PubMed ID: 34949183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.
    Noujeim JP; Belahsen Y; Lefebvre Y; Lemort M; Deforche M; Sirtaine N; Martin R; Roumeguère T; Peltier A; Diamand R
    Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):575-580. PubMed ID: 36509930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.
    Ghai S; Perlis N; Atallah C; Jokhu S; Corr K; Lajkosz K; Incze PF; Zlotta AR; Jain U; Fleming H; Finelli A; van der Kwast TH; Haider MA
    Radiology; 2022 Nov; 305(2):390-398. PubMed ID: 35852425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study.
    Qiu DX; Li J; Zhang JW; Chen MF; Gao XM; Tang YX; Zhang Y; Yi XP; Yin HL; Gan Y; Wang GL; Zu XB; Hu S; Cai Y
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2821-2832. PubMed ID: 34860277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study.
    Krausewitz P; Fostitsch D; Weiten R; Kluemper N; Stein J; Luetkens J; Kristiansen G; Ellinger J; Ritter M
    World J Urol; 2023 Jan; 41(1):19-25. PubMed ID: 36477403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.
    Ma TM; Tosoian JJ; Schaeffer EM; Landis P; Wolf S; Macura KJ; Epstein JI; Mamawala M; Carter HB
    Eur Urol; 2017 Feb; 71(2):174-180. PubMed ID: 27236496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate.
    Wang L; Wang X; Zhao W; Zhao Z; Li Z; Fei S; Zhu H; Ji X; Yang B; Li N; Na Y
    BMC Urol; 2019 Nov; 19(1):107. PubMed ID: 31684917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
    Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
    Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.